07.03.2016
- The plot surrounding the proposed merger of Dow and DuPont continues to thicken. After the companies late last week signaled that the deal could take longer due to regulatory...
07.03.2016
- French pharmaceutical company Ipsen is paying up to $855 million for the rights to Exelixis’ cancer drug Cabozantinib. Under the deal, Exelixis gains exclusive commercialization...
04.03.2016
- Despite a weaker than expected 2015 and an especially disappointing end to the year, the outlook for German chemical producers in 2016 is mostly positive, the industry association...
04.03.2016
- The US Environmental Protection Agency (EPA) has canceled the registration of the herbicide flubendiamide, believed to pose a risk to fish, as the two manufacturers, Bayer...
04.03.2016
- UK companies Centauri Therapeutics and Horizon Discovery have formed a joint venture targeting the rapidly growing immuno-oncology market. The newly formed company Avvinity...
04.03.2016
- Despite recent reports of progress in aligning production segments and geographic locations, the merger of Dow and DuPont may not take shape as fast as the future partners...
03.03.2016
- Privately owned German drugmaker Boehringer Ingelheim is talking to AbbVie of the US about a partnership in oncology potentially worth billions of dollars, the news agency...
03.03.2016
- Saudi Arabian chemical giant SABIC has acquired a majority stake in Fibre Reinforced Thermoplastics, a producer of engineered thermoplastic, fiber-reinforced unidirectional (“UD”)...
03.03.2016
- Canada-based, US-managed drug firm Valeant Pharmaceuticals has confirmed it is under another investigation by the Securities and Exchange Commission (SEC), the latest in a string...
02.03.2016
- US law firm Zeldes Haeggquist & Eck has started investigating a possible violation of federal securities laws by Indian generics manufacturer Dr. Reddy’s Laboratories and US...
